Advanced Inhibition of Undesired Human Hair Growth by PPARγ Modulation

    Yuval Ramot, Arianna Mastrofrancesco, Erika Herczeg-Lisztes, Tamás Bı́ró, Mauro Picardo, Jennifer E. Kloepper, Ralf Paus
    Image of study
    TLDR GMG-43AC may help reduce unwanted hair growth and treat certain hair loss conditions.
    The study explored the potential of GMG-43AC, a selective PPARγ modulator, to inhibit unwanted human hair growth by inducing premature hair follicle (HF) regression (catagen) while preserving HF epithelial progenitor cells. GMG-43AC was tested on organ-cultured HFs from a female patient, showing a significant increase in catagen phase HFs and upregulation of keratins K15 and K19, indicating a positive impact on HF progenitor cells. Additionally, GMG-43AC demonstrated anti-inflammatory properties by preventing IL-6 expression in normal human keratinocytes exposed to inflammatory stimuli. The findings suggested that GMG-43AC could be a promising candidate for managing hirsutism and potentially treating cicatricial alopecia like lichen planopilaris due to its anti-inflammatory and stem cell-protective effects.
    Discuss this study in the Community →

    Research cited in this study

    4 / 4 results

    Related Community Posts Join

    6 / 8 results

    Related Research

    3 / 3 results